FormationQ & Hartree Centre back UK quantum adoption
FormationQ and the Hartree Centre have formed a strategic partnership to support the adoption of quantum computing across…
Britain’s pharma policy is a gift to Ireland
Share this article Here’s a fun fact for you: Ireland, a country of just over 5 million people,…
Barclays map shows UK equity investment surges 26%
Barclays has launched its Regional Investment Map, which shows that UK businesses raised GBP £14.4 billion in equity…
GSK invests £400m to move research hub to Cambridge
Pharma giant GSK is to invest £400m into the creation of a new global centre of excellence in…
BIOSECURE Act for UK and EU life sciences companies: navigating China–US contracting risks, James Johnston, Claire Smith
The global biotech market is moving along two conflicting paths. On the one hand, Western pharmaceutical companies are…
Sidley steers Sino Biopharm, AstraZeneca licence agreement
Sidley Austin has advised Sino Biopharmaceutical (Sino Biopharm) on an exclusive licence agreement between its subsidiary, Chia Tai…
Ten organisations carried out half of all animal research in Great Britain in 2025
99% of procedures carried out in mice, fish, rats, and birds82% of procedures caused pain equivalent to, or…
UK chief executives boost M&A as AI drives dealmaking rise
UK chief executives are increasing merger and acquisition activity to support AI transformation, according to EY-Parthenon, with 87%…
State capital meets supercomputing – the UK Government’s Sovereign AI fund announcement, Oliver Alsop
At a glance The UK Government has launched Sovereign AI, a £500m state-backed investment fund established to invest…
British Business Bank backs Episode 1 Fund IV with GBP £35M
The British Business Bank has committed up to GBP £35 million to Episode 1’s Fund IV, marking its…
UK and US lock in pharmaceutical deal – POLITICO
In an announcement on Thursday, the government confirmed it had agreed a text with the U.S. that exempted…